Lactobacillus fermentum CECT5716: a novel alternative for the prevention of vascular disorders in a mouse model of systemic lupus erythematosus
- PMID: 31173526
- DOI: 10.1096/fj.201900545RR
Lactobacillus fermentum CECT5716: a novel alternative for the prevention of vascular disorders in a mouse model of systemic lupus erythematosus
Abstract
The aim of the present study was to examine whether the immune-modulatory bacteria Lactobacillus fermentum CECT5716 (LC40) ameliorates disease activity and cardiovascular complications in a female mouse model of lupus. Eighteen-week-old NZBWF1 [systemic lupus erythematosus (SLE)] and NZW/LacJ (control) mice were treated with vehicle or LC40 (5 × 108 colony-forming units/d) for 15 wk. LC40 treatment reduced lupus disease activity, blood pressure, cardiac and renal hypertrophy, and splenomegaly in SLE mice. LC40 reduced the elevated T, B, regulatory T cells (Treg), and T helper (Th)-1 cells in mesenteric lymph nodes of lupus mice. LC40 lowered the higher plasma concentration of proinflammatory cytokines observed in lupus mice. Aortas from SLE mice showed reduced endothelium-dependent vasodilator responses to acetylcholine. Endothelial dysfunction found in SLE is related to an increase of both NADPH oxidase-driven superoxide production and eNOS phosphorylation at the inhibitory Thr495. These activities returned to normal values after a treatment with LC40. Probiotic administration to SLE mice reduced plasma LPS levels, which might be related to an improvement of the gut barrier integrity. LC40 treatment increases the Bifidobacterium count in gut microbiota of SLE mice. In conclusion, our findings identify the gut microbiota manipulation with LC40 as an alternative approach to the prevention of SLE and its associated vascular damage.-Toral, M., Robles-Vera, I., Romero, M., de la Visitación, N., Sánchez, M., O'Valle, F., Rodriguez-Nogales, A., Gálvez, J., Duarte, J., Jiménez, R. Lactobacillus fermentum CECT5716: a novel alternative for the prevention of vascular disorders in a mouse model of systemic lupus erythematosus.
Keywords: endothelial dysfunction; gut dysbiosis; hypertension; oxidative stress; probiotics.
Similar articles
-
Lactobacillus fermentum CECT5716 prevents renal damage in the NZBWF1 mouse model of systemic lupus erythematosus.Food Funct. 2020 Jun 24;11(6):5266-5274. doi: 10.1039/d0fo00578a. Food Funct. 2020. PMID: 32458936
-
Probiotics Prevent Hypertension in a Murine Model of Systemic Lupus Erythematosus Induced by Toll-Like Receptor 7 Activation.Nutrients. 2021 Jul 31;13(8):2669. doi: 10.3390/nu13082669. Nutrients. 2021. PMID: 34444829 Free PMC article.
-
The Probiotic Lactobacillus fermentum Prevents Dysbiosis and Vascular Oxidative Stress in Rats with Hypertension Induced by Chronic Nitric Oxide Blockade.Mol Nutr Food Res. 2018 Oct;62(19):e1800298. doi: 10.1002/mnfr.201800298. Epub 2018 Aug 7. Mol Nutr Food Res. 2018. PMID: 30028078
-
Protective Effects of Probiotic Consumption in Cardiovascular Disease in Systemic Lupus Erythematosus.Nutrients. 2019 Nov 5;11(11):2676. doi: 10.3390/nu11112676. Nutrients. 2019. PMID: 31694260 Free PMC article. Review.
-
Gut microbiota: a newly identified environmental factor in systemic lupus erythematosus.Front Immunol. 2023 Jul 18;14:1202850. doi: 10.3389/fimmu.2023.1202850. eCollection 2023. Front Immunol. 2023. PMID: 37533870 Free PMC article. Review.
Cited by
-
The Therapeutic Effects of Probiotic on Systemic Lupus Erythematosus in Lupus Mice Models: A Systematic Review.Probiotics Antimicrob Proteins. 2024 May 28. doi: 10.1007/s12602-024-10297-1. Online ahead of print. Probiotics Antimicrob Proteins. 2024. PMID: 38806966 Review.
-
Border Control: The Role of the Microbiome in Regulating Epithelial Barrier Function.Cells. 2024 Mar 8;13(6):477. doi: 10.3390/cells13060477. Cells. 2024. PMID: 38534321 Free PMC article. Review.
-
Metabolic Modulators in Cardiovascular Complications of Systemic Lupus Erythematosus.Biomedicines. 2023 Nov 25;11(12):3142. doi: 10.3390/biomedicines11123142. Biomedicines. 2023. PMID: 38137363 Free PMC article. Review.
-
Probiotics as a complementary treatment in systemic lupus erythematosus: A systematic review.Health Sci Rep. 2023 Oct 23;6(10):e1640. doi: 10.1002/hsr2.1640. eCollection 2023 Oct. Health Sci Rep. 2023. PMID: 37877130 Free PMC article.
-
Possible Role of Dysbiosis of the Gut Microbiome in SLE.Curr Rheumatol Rep. 2023 Dec;25(12):247-258. doi: 10.1007/s11926-023-01115-8. Epub 2023 Sep 22. Curr Rheumatol Rep. 2023. PMID: 37737528 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases